SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Ji-Won Jung, Nana H. Overgaard, Michael T. Burke, Nicole Isbel, Ian H. Frazer, Fiona Simpson, James W. Wells, Does the nature of residual immune function explain the differential risk of non-melanoma skin cancer development in immunosuppressed organ transplant recipients?, International Journal of Cancer, 2015, 136, 9
  2. 2
    Tae Hyun Ryu, Sung Hoo Choi, Peel Jung, Kang Hun Lee, Han Se Kim, Joon Seok Oh, Seung Min Kim, Young Hun Sin, Joong Kyung Kim, A Case of Squamous Cell Carcinoma in Nasal Cavity Treated with Conversion to Sirolimus in a Patient with Kidney Transplantation, The Journal of the Korean Society for Transplantation, 2014, 28, 2, 83

    CrossRef

  3. 3
    Nazanin Majd, Kazutaka Sumita, Hirofumi Yoshino, Dillon Chen, Jumpei Terakawa, Takiko Daikoku, Satoshi Kofuji, Richard Curry, Trisha M. Wise-Draper, Ronald E. Warnick, Jessica Guarnaschelli, Atsuo T. Sasaki, A Review of the Potential Utility of Mycophenolate Mofetil as a Cancer Therapeutic, Journal of Cancer Research, 2014, 2014, 1

    CrossRef

  4. 4
    F. Y. Hsiao, W. W. Y. Hsu, Epidemiology of post-transplant malignancy in Asian renal transplant recipients: a population-based study, International Urology and Nephrology, 2014, 46, 4, 833

    CrossRef

  5. You have free access to this content5
    R. San-Juan, P. Comoli, S. Caillard, B. Moulin, H. H. Hirsch, P. Meylan, Epstein-Barr virus-related post-transplant lymphoproliferative disorder in solid organ transplant recipients, Clinical Microbiology and Infection, 2014, 20,
  6. 6
    Manuel Rodríguez-Perálvarez, Manuel De la Mata, Andrew K. Burroughs, Liver transplantation, Current Opinion in Organ Transplantation, 2014, 19, 3, 253

    CrossRef

  7. 7
    Martin Mynarek, Kais Hussein, Hans H. Kreipe, Britta Maecker-Kolhoff, Malignancies after pediatric kidney transplantation: more than PTLD?, Pediatric Nephrology, 2014, 29, 9, 1517

    CrossRef

  8. 8
    Kan Chen, Kwan Man, Herold J. Metselaar, Harry L. A. Janssen, Maikel P. Peppelenbosch, Qiuwei Pan, Rationale of personalized immunosuppressive medication for hepatocellular carcinoma patients after liver transplantation, Liver Transplantation, 2014, 20, 3
  9. 9
    M. Opgenoorth, C. Hugo, Tumoren nach Nierentransplantation, Forum, 2014, 29, 2, 125

    CrossRef

  10. 10
    Adam Bagg, Cherie H. Dunphy, Immunosuppressive and immunomodulatory therapy-associated lymphoproliferative disorders, Seminars in Diagnostic Pathology, 2013, 30, 2, 102

    CrossRef

  11. 11
    Jane Li, Alvin H Chong, Jack Green, Robert Kelly, Christopher Baker, Mycophenolate use in dermatology: A clinical audit, Australasian Journal of Dermatology, 2013, 54, 4
  12. 12
    Zeina Al-Mansour, Beverly P. Nelson, Andrew M. Evens, Post-Transplant Lymphoproliferative Disease (PTLD): Risk Factors, Diagnosis, and Current Treatment Strategies, Current Hematologic Malignancy Reports, 2013, 8, 3, 173

    CrossRef

  13. 13
    Martin Mynarek, Tilmann Schober, Uta Behrends, Britta Maecker-Kolhoff, Posttransplant Lymphoproliferative Disease after Pediatric Solid Organ Transplantation, Clinical and Developmental Immunology, 2013, 2013, 1

    CrossRef

  14. 14
    Gu-Min Cho, Myung-Nam Bae, Young-Hee Jung, Hye-Sun Kang, In-Woon Baek, Ki-Jo Kim, Chul-Soo Cho, Spontaneous Remission of Hodgkin's Lymphoma in a Patient with Systemic Lupus Erythematosus after Withdrawal of Methotrexate, Journal of Rheumatic Diseases, 2013, 20, 4, 238

    CrossRef

  15. 15
    M. Opgenoorth, C. Hugo, Tumoren nach Nierentransplantation, best practice onkologie, 2013, 8, 1, 38

    CrossRef

  16. 16
    M. Opgenoorth, C. Hugo, Tumoren nach Nierentransplantation, Der Onkologe, 2013, 19, 3, 237

    CrossRef

  17. 17
    Guillaume Ploussard, Damien Chambade, Paul Meria, François Gaudez, Edouard Tariel, Jérôme Verine, Cédric De Bazelaire, Marie-Noëlle Peraldi, Denis Glotz, François Desgrandchamps, Pierre Mongiat-Artus, Biopsy-confirmed de novo renal cell carcinoma (RCC) in renal grafts: a single-centre management experience in a 2396 recipient cohort, BJU International, 2012, 109, 2
  18. 18
    Natasha Chandok, Kymberly D. Watt, Burden of de novo malignancy in the liver transplant recipient, Liver Transplantation, 2012, 18, 11
  19. 19
    P. Braconnier, V. del Marmol, N. Broeders, M. Kianda, A. Massart, A. Lemy, L. Ghisdal, A. Le Moine, P. Madhoun, J. Racape, D. Abramowicz, K. M. Wissing, Combined introduction of anti-IL2 receptor antibodies, mycophenolic acid and tacrolimus: effect on malignancies after renal transplantation in a single-centre retrospective cohort study, Nephrology Dialysis Transplantation, 2012, 27, 6, 2547

    CrossRef

  20. 20
    Michal Herman-Edelstein, Benaya Rozen-Zvi, Boris Zingerman, Shelly Lichtenberg, Tsipora Malachi, Uzi Gafter, Yaacov Ori, Effect of immunosuppressive drugs on DNA repair in human peripheral blood mononuclear cells, Biomedicine & Pharmacotherapy, 2012, 66, 2, 111

    CrossRef

  21. 21
    Yaacov Ori, Michal Herman-Edelstein, Boris Zingerman, Benaya Rozen-Zvi, Uzi Gafter, Tsipora Malachi, Anat Gafter-Gvili, Effect of immunosuppressive drugs on spontaneous DNA repair in human peripheral blood mononuclear cells, Biomedicine & Pharmacotherapy, 2012, 66, 6, 409

    CrossRef

  22. You have free access to this content22
    S. Caillard, F. X. Lamy, C. Quelen, J. Dantal, Y. Lebranchu, P. Lang, M. Velten, B Moulin, Epidemiology of Posttransplant Lymphoproliferative Disorders in Adult Kidney and Kidney Pancreas Recipients: Report of the French Registry and Analysis of Subgroups of Lymphomas, American Journal of Transplantation, 2012, 12, 3
  23. 23
    Vidhya Murukesan, Sandeep Mukherjee, Managing Post-Transplant Lymphoproliferative Disorders in Solid-Organ Transplant Recipients, Drugs, 2012, 72, 12, 1631

    CrossRef

  24. 24
    Marina Eskin-Schwartz, Michael David, Daniel Mimouni, Mycophenolate Mofetil for the Management of Autoimmune Bullous Diseases, Immunology and Allergy Clinics of North America, 2012, 32, 2, 309

    CrossRef

  25. 25
    Jason Andre, Afshin Parsikia, Corrado Minimo, Kamran Khanmoradi, Stalin Campos, Radi Zaki, Jorge Ortiz, Soft Tissue Sarcoma at a Dialysis Access Site in a Transplant Recipient, Experimental and Clinical Transplantation, 2012, 10, 4, 410

    CrossRef

  26. 26
    M. Opgenoorth, C. Hugo, Tumoren nach Nierentransplantation, Der Nephrologe, 2012, 7, 5, 435

    CrossRef

  27. 27
    B. Detti, S. Scoccianti, D. Franceschini, D. Villari, D. Greto, S. Cipressi, A. Sardaro, M. Zanassi, T. Cai, G. Biti, Adjuvant Radiotherapy for a Prostate Cancer After Renal Transplantation and Review of the Literature, Japanese Journal of Clinical Oncology, 2011, 41, 11, 1282

    CrossRef

  28. 28
    Sophie Caillard, Olivier Imhoff, Bruno Moulin, Complications hématologiques malignes, en particulier lymphoprolifératives, après transplantation, Néphrologie & Thérapeutique, 2011, 7, 6, 500

    CrossRef

  29. 29
    C. Ponticelli, Herpes viruses and tumours in kidney transplant recipients. The role of immunosuppression, Nephrology Dialysis Transplantation, 2011, 26, 6, 1769

    CrossRef

  30. 30
    Rolf Weimer, Sabine Deisz, Hartmut Dietrich, Fabrice Renner, Rolf-Hasso Bödeker, Volker Daniel, Shirin Kamali-Ernst, Wolfgang Ernst, Winfried Padberg, Gerhard Opelz, Impact of maintenance immunosuppressive regimens – balance between graft protective suppression of immune functions and a near physiological immune response, Transplant International, 2011, 24, 6
  31. 31
    Gyula Végső, Melinda Hajdu, Anna Sebestyén, Lymphoproliferative Disorders After Solid Organ Transplantation—Classification, Incidence, Risk Factors, Early Detection and Treatment Options, Pathology & Oncology Research, 2011, 17, 3, 443

    CrossRef

  32. 32
    Daan Dierickx, Thomas Tousseyn, Christiane De Wolf-Peeters, Jacques Pirenne, Gregor Verhoef, Management of posttransplant lymphoproliferative disorders following solid organ transplant: an update, Leukemia & Lymphoma, 2011, 52, 6, 950

    CrossRef

  33. 33
    Marina Eskin-Schwartz, Michael David, Daniel Mimouni, Mycophenolate Mofetil for the Management of Autoimmune Bullous Diseases, Dermatologic Clinics, 2011, 29, 4, 555

    CrossRef

  34. 34
    Spyridoula Doukaki, Giuseppe Pistone, Mario Aricò, Maria Rita Bongiorno, Pharmacokinetic evaluation of mycophenolate mofetil for pemphigus, Expert Opinion on Drug Metabolism & Toxicology, 2011, 7, 2, 237

    CrossRef

  35. 35
    S. Tuttleton Arron, L. Jennings, I. Nindl, F. Rosl, J.N. Bouwes Bavinck, D. Seçkin, M. Trakatelli, G.M. Murphy, Viral oncogenesis and its role in nonmelanoma skin cancer, British Journal of Dermatology, 2011, 164, 6
  36. 36
    E.K. Geissler, Can Immunosuppressive Strategies Be Used to Reduce Cancer Risk in Renal Transplant Patients?, Transplantation Proceedings, 2010, 42, 9, S32

    CrossRef

  37. 37
    Nicolás Manito, Juan F. Delgado, Maria G. Crespo-Leiro, Francisco González-Vílchez, Luis Almenar, José M. Arizón, Beatriz Díaz, Juan Fernández-Yáñez, Sònia Mirabet, Jesús Palomo, José L. Rodríguez Lambert, Eulàlia Roig, Javier Segovia, Clinical recommendations for the use of everolimus in heart transplantation, Transplantation Reviews, 2010, 24, 3, 129

    CrossRef

  38. You have free access to this content38
    Anne Parker, Kristin Bowles, J. Andrew Bradley, Vincent Emery, Carrie Featherstone, Girish Gupte, Robert Marcus, Jayan Parameshwar, Alan Ramsay, Charles Newstead, Diagnosis of post-transplant lymphoproliferative disorder in solid organ transplant recipients – BCSH and BTS Guidelines, British Journal of Haematology, 2010, 149, 5
  39. 39
    R. Marcén, C. Galeano, A. Fernández-Rodriguez, S. Jiménez-Alvaro, J.L. Teruel, M. Rivera, F.J. Burgos, C. Quereda, Effects of the New Immunosuppressive Agents on the Occurrence of Malignancies After Renal Transplantation, Transplantation Proceedings, 2010, 42, 8, 3055

    CrossRef

  40. 40
    K. A. Mackenzie, J. E. Wells, K. L. Lynn, J. W. Simcock, B. A. Robinson, J. A. Roake, M. J. Currie, First and subsequent nonmelanoma skin cancers: incidence and predictors in a population of New Zealand renal transplant recipients, Nephrology Dialysis Transplantation, 2010, 25, 1, 300

    CrossRef

  41. 41
    Kwang-Woong Lee, Kyung-Suk Suh, Liver Transplantation for Advanced Hepatocellular Carcinoma, The Journal of the Korean Society for Transplantation, 2010, 24, 1, 4

    CrossRef

  42. 42
    Inés Rama, Josep M. Grinyó, Malignancy after renal transplantation: the role of immunosuppression, Nature Reviews Nephrology, 2010, 6, 9, 511

    CrossRef

  43. 43
    Roberto Marcén, Immunosuppressive Drugs in Kidney Transplantation, Drugs, 2009, 69, 16, 2227

    CrossRef

  44. 44
    Jin Min Kong, Malignancy in Renal Transplant Recipients, The Journal of the Korean Society for Transplantation, 2009, 23, 2, 130

    CrossRef

  45. 45
    C. Hinrichs, P. Reinke, Moderne Immunsuppression, Der Onkologe, 2009, 15, 6, 557

    CrossRef

  46. 46
    F Birnbaum, S Mayweg, A Reis, D Böhringer, B Seitz, K Engelmann, E M Messmer, T Reinhard, Mycophenolate mofetil (MMF) following penetrating high-risk keratoplasty: long-term results of a prospective, randomised, multicentre study, Eye, 2009, 23, 11, 2063

    CrossRef

  47. 47
    U. Kunzendorf, L. Renders, Tumoren nach Nierentransplantation, Der Nephrologe, 2009, 4, 3, 230

    CrossRef

  48. 48
    Rachel B Jones, Michael Walsh, Kenneth GC Smith, What is the value of mycophenolate mofetil as induction and maintenance therapy in lupus nephritis?, Current Opinion in Rheumatology, 2009, 21, 3, 256

    CrossRef

  49. 49
    M. Fischereder, Cancer in patients on dialysis and after renal transplantation, Nephrology Dialysis Transplantation, 2008, 23, 8, 2457

    CrossRef

  50. 50
    Germaine Wong, Jeremy R. Chapman, Cancers after renal transplantation, Transplantation Reviews, 2008, 22, 2, 141

    CrossRef

  51. 51
    S. Domhan, M. Zeier, A. Abdollahi, Immunosuppressive therapy and post-transplant malignancy, Nephrology Dialysis Transplantation, 2008, 24, 4, 1097

    CrossRef

  52. 52
    Piero Stratta, Veronica Morellini, Claudio Musetti, Ernesto Turello, Daniela Palmieri, Elisa Lazzarich, Tiziana Cena, Corrado Magnani, Malignancy after kidney transplantation: results of 400 patients from a single center, Clinical Transplantation, 2008, 22, 4
  53. 53
    F. Kleinclauss, M. Gigante, Y. Neuzillet, M. Mouzin, N. Terrier, L. Salomon, F. Iborra, J. Petit, L. Cormier, E. Lechevallier, Prostate cancer in renal transplant recipients, Nephrology Dialysis Transplantation, 2008, 23, 7, 2374

    CrossRef

  54. 54
    David Philibert, Daniel Cattran, Remission of proteinuria in primary glomerulonephritis: we know the goal but do we know the price?, Nature Clinical Practice Nephrology, 2008, 4, 10, 550

    CrossRef

  55. 55
    Y. Chenggang, H. Yan, Z. Xudong, L. Binglun, Z. Hui, M. Xianjie, Y. Li, F. Xing, L. Yunjing, L. Kaihua, L. Huiyuan, Z. Yan, Z. Guoyou, G. Shuzhong, Some Issues in Facial Transplantation, American Journal of Transplantation, 2008, 8, 10
  56. 56
    W.L. Ho, G.M. Murphy, Update on the pathogenesis of post-transplant skin cancer in renal transplant recipients, British Journal of Dermatology, 2008, 158, 2
  57. 57
    Ulrich Kunzendorf, Ekkehard Ziegler, Facharzt Nephrologie, 2008,

    CrossRef

  58. 58
    William E. Braun, Therapy in Nephrology & Hypertension, 2008,

    CrossRef

  59. 59
    Brahm Vasudev, Sundaram Hariharan, Cancer after renal transplantation, Current Opinion in Nephrology and Hypertension, 2007, 16, 6, 523

    CrossRef

  60. 60
    Alex Gutierrez-Dalmau, Josep M Campistol, Immunosuppressive Therapy and Malignancy in Organ Transplant Recipients, Drugs, 2007, 67, 8, 1167

    CrossRef

  61. 61
    J-L Bosmans, G A Verpooten, Malignancy after kidney transplantation: Still a challenge, Kidney International, 2007, 71, 12, 1197

    CrossRef

  62. 62
    Jeffrey Zwerner, David Fiorentino, Mycophenolate mofetil, Dermatologic Therapy, 2007, 20, 4
  63. 63
    C D Wimmer, M Rentsch, A Crispin, W D Illner, H Arbogast, C Graeb, K-W Jauch, M Guba, The janus face of immunosuppression – de novo malignancy after renal transplantation: the experience of the Transplantation Center Munich, Kidney International, 2007, 71, 12, 1271

    CrossRef

  64. 64
    M. Ketteler, Tumorerkrankungen nach Nierentransplantation, Der Nephrologe, 2007, 2, 3, 182

    CrossRef

  65. 65
    Medical Complications of Kidney Transplantation, 2007,

    CrossRef

  66. 66
    S. Caillard, O. Imhoff, B. Moulin, Complications hématologiques malignes, en particulier lymphoprolifératives, après transplantation, EMC - Néphrologie, 2006, 1, 1, 1

    CrossRef

  67. 67
    Gudrun E. Koehl, Andreas Gaumann, Carl Zuelke, Anna Hoehn, Ferdinand Hofstaedter, Hans J. Schlitt, Edward K. Geissler, Development of De Novo Cancer in p53 Knock-Out Mice is Dependent on the Type of Long-Term Immunosuppression Used, Transplantation, 2006, 82, 6, 741

    CrossRef

  68. 68
    Titte R Srinivas, Jesse D Schold, Herwig-Ulf Meier-Kriesche, Mycophenolate mofetil: long-term outcomes in solid organ transplantation, Expert Review of Clinical Immunology, 2006, 2, 4, 495

    CrossRef

  69. 69
    Maria Boratyńska, Sławomir C. Zmonarski, Marian Klinger, Reccurence of Kaposi's sarcoma after increased exposure to sirolimus, International Immunopharmacology, 2006, 6, 13-14, 2018

    CrossRef

  70. 70
    Oriol Bestard, Josep M. Cruzado, Josep M. Grinyó, General Malignancy after Organ Transplantation,
  71. 71
    Karen L. Hardinger, Daniel C. Brennan, Christina L.M. Klein, Maintenance Immunosuppressive Therapy,